D. Lynn Kirkpatrick

President, Chief Executive Officer & Director at Ensysce Biosciences, Inc.

D. Lynn Kirkpatrick

D. Lynn Kirkpatrick

President, Chief Executive Officer & Director at Ensysce Biosciences, Inc.

Overview
Career Highlights

Ensysce Biosciences, Inc.
Phusis Therapeutics, Inc.
ProlX Pharmaceuticals Corp.

RelSci Relationships

91

Number of Boards

3

Birthday

1957

Age

64

Relationships
RelSci Relationships are individuals D. Lynn Kirkpatrick likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Ensysce Biosciences, Inc.

Relationship likelihood: Strong

Founding Governor at The City Club of San Francisco, Inc.

Relationship likelihood: Strong

Vice President at XOMA Corp.

Relationship likelihood: Strong

Scientific Co-Founder at Phusis Therapeutics, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Signature Therapeutics, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer at Ensysce Biosciences, Inc.

Relationship likelihood: Strong

Scientific Co-Founder at Phusis Therapeutics, Inc.

Relationship likelihood: Strong

Scientific Co-Founder at Phusis Therapeutics, Inc.

Relationship likelihood: Strong

Director at Tri-Institutional Therapeutics Discovery Institute, Inc.

Relationship likelihood: Strong

Former Senior Vice President, Oncology at Coherus BioSciences, Inc.

Relationship likelihood: Strong

Paths to D. Lynn Kirkpatrick
Potential Connections via
Relationship Science
You
D. Lynn Kirkpatrick
President, Chief Executive Officer & Director at Ensysce Biosciences, Inc.
Education

The primary role of the university is to provide post-secondary instruction and research in the humanities, sciences, social sciences and other areas of human, intellectual, cultural, social and physical development.

Career History
President, Chief Executive Officer & Director
2009 - Current

Ensysce Biosciences, Inc. supplies drugs for pain and cancer markets. Its technologies include opioid drug abuse-resistant, single-walled carbon nanotubes, SWCNT-immuno and gene therapy and BIO-MD prodrug technology. The company was founded by Bob G. Gower and William H.C. Chang in 2008 and is headquartered in San Diego, CA.

President & Chief Executive Officer
Current

Phusis Therapeutics, Inc. is an American private company located in Houston, TX, that develops novel targeted small molecule therapeutics.

Chief Scientific Officer
Prior - 2007

Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy

Boards & Committees
Chair, Board of Directors
Current

Phusis Therapeutics, Inc. is an American private company located in Houston, TX, that develops novel targeted small molecule therapeutics.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by D. Lynn Kirkpatrick. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of D. Lynn Kirkpatrick's profile does not indicate a business or promotional relationship of any kind between RelSci and D. Lynn Kirkpatrick.